.jpg)
Listen here or where you enjoy podcasts!
In this episode, we’re diving into a condition that affects over 10 million Americans but often flies under the radar—osteoporosis. Following up on last month’s discussion on insomnia, we’re once again tackling a silent, underdiagnosed condition that has major implications for older adults.
Chris breaks down the basics of bone biology, the surprising impact of fractures—especially hip fractures—and the risk factors that contribute to osteoporosis. From screening guidelines and supplement strategies to the most common pharmacologic treatments, this episode is packed with practical insights for healthcare providers.
All this, plus medication news, trivia, and an appearance from Chris' dog.
Links to material referenced in this episode:
Into the Clinic:
Novel Migraine Treatment Shows Mixed Results in Phase 3 Efficacy Trial
FDA Approves Atzumi, Nasal Powder Formulation of DHE, for Acute Treatment of Migraine
FDA Approves Auto-Injector for Migraine, Cluster Headache
FDA approves mepolizumab for COPD with eosinophilic phenotype
Osteoporosis Discussion:
The clinician’s guide to prevention and treatment of osteoporosis
Trivia Capsule:
Bisphosphonates for osteoporosis: from bench to clinic
Bisphosphonates in osteoporosis
